Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Actuate Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ACTU.
You can purchase shares of Actuate Therapeutics (NASDAQ:ACTU) through any online brokerage.
Other companies in Actuate Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Macrogenics (NASDAQ:MGNX), Renovaro (NASDAQ:RENB), Zentalis Pharma (NASDAQ:ZNTL) and Elicio Therapeutics (NASDAQ:ELTX).
Actuate Therapeutics has a consensus price target of $20.00.
The stock price for Actuate Therapeutics (NASDAQ: ACTU) is $7.375 last updated March 17, 2025 at 9:55 AM EDT.
There are no upcoming dividends for Actuate Therapeutics.
Actuate Therapeutics’s Q1 earnings are confirmed for Wednesday, May 21, 2025.
There is no upcoming split for Actuate Therapeutics.
Actuate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.